NYSEMKT: IGC
Igc Pharma Inc Stock Ownership - Who owns Igc Pharma?

Insider buying vs selling

Have Igc Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Claudia GrimaldiPFO2026-04-01138,462$0.26
$36.00kBuy
Ram MukundaCEO2026-04-01323,077$0.26
$84.00kBuy

1 of 1

IGC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IGC insiders and whales buy or sell their stock.

IGC Shareholders

What type of owners hold Igc Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ram Mukunda6.06%5,984,839$1.92MInsider
Bradbury Strategic Investment Fund A Cayman Islands Registration No Cr3598575.06%5,000,000$1.60MInsider
James P. Moran2.20%2,178,137$697.00kInsider
Richard K. Prins1.56%1,541,251$493.20kInsider
Db Zwirn Co LP1.50%1,485,404$475.33kInsider
Claudia Grimaldi1.39%1,372,714$439.27kInsider
Vanguard Group Inc1.16%1,149,268$367.77kInstitution
Ranga C. Krishna1.08%1,068,461$341.91kInsider
Renaissance Technologies LLC0.93%919,641$294.29kInstitution
Geode Capital Management LLC0.87%860,477$275.35kInstitution

1 of 3

IGC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IGC4.89%21.78%Net BuyingNet Buying
NXTC11.68%88.32%
PLUR0.02%99.98%Net Buying
BTAI1.76%98.24%
DARE3.71%96.29%

Igc Pharma Stock Ownership FAQ

Who owns Igc Pharma?

Igc Pharma (NYSEMKT: IGC) is owned by 4.89% institutional shareholders, 21.78% Igc Pharma insiders, and 73.33% retail investors. Ram Mukunda is the largest individual Igc Pharma shareholder, owning 5.98M shares representing 6.06% of the company. Ram Mukunda's Igc Pharma shares are currently valued at $2.00M.

If you're new to stock investing, here's how to buy Igc Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.